Chemerin activates fibroblast-like synoviocytes in patients with rheumatoid arthritis

First Page		Document Content
Health Systemic scleroderma Autoantibody Anti-nuclear antibody Systemic lupus erythematosus Anti-Scl-70 antibodies Scleromyositis Autoimmunity RNA polymerase Anatomy Autoimmune diseases Biology		Chemerin activates fibroblast-like synoviocytes in patients with rheumatoid arthritis Add to Reading List Source URL: www.ncbi.nlm.nih.gov Download Document from Source Website File Size: 630,97 KB Share Document on Facebook

	Technology Opportunity, Ref. No. UZNovel Pharmacological Treatment of Scleroderma This invention relates to a novel pharmacological treatment of scleroderma comprising the administration of miR-29. DocID: 1pOlw - View Document
	Downloaded from ard.bmj.com on March 28, [removed]Published by group.bmj.com Supplement New approaches to the assessment and treatment of the idiopathic inflammatory myopathies DocID: GhWU - View Document
	Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment DocID: F0VY - View Document
	Research Networking Programme European Myositis Network (EuMyoNet) Standing Committee for the Medical Sciences (European Medical Research Councils, EMRC) DocID: fEUj - View Document
	Adults aren’t the only one who get DocID: 9qQ8 - View Document